Counts J L, Goodman J I
Department of Pharmacology and Toxicology, Michigan State University, East Lansing 48824, USA.
Regul Toxicol Pharmacol. 1995 Jun;21(3):418-21. doi: 10.1006/rtph.1995.1056.
The purpose of the bioassay is not to simply find chemicals that can be labeled as carcinogens. On the contrary, the overall goal is to provide a reasonable assessment of the possible hazard that a chemical might pose to people under realistic conditions of exposure. This paper focuses upon the doses commonly used in the bioassay within the context that dose influences mechanism and, over a wide range of doses, mechanism changes with changing dose. Thus, a carcinogenic effect observed at a high dose is not necessarily expected to occur at lower doses. A variety of examples are provided to illustrate the points that (a) any high dose, no matter how high, that permits test animals to live long enough to develop tumors is not an appropriate criterion for defining an acceptable high dose to employ in a carcinogen bioassay; and (b) emphasis should be placed upon research that may discern probable thresholds for the carcinogenic effect of chemicals, especially nongenotoxic chemicals.
生物测定的目的并非仅仅是找出可被标记为致癌物的化学物质。相反,其总体目标是对一种化学物质在实际接触条件下可能对人类造成的潜在危害提供合理评估。本文聚焦于生物测定中常用的剂量,在此背景下,剂量会影响作用机制,并且在很宽的剂量范围内,作用机制会随剂量变化而改变。因此,在高剂量下观察到的致癌效应不一定会在低剂量下出现。文中提供了各种示例来说明以下几点:(a) 任何高剂量,无论多高,只要能让实验动物存活足够长时间以发生肿瘤,都不是定义致癌物生物测定中可接受高剂量的合适标准;(b) 应着重开展可能辨别化学物质致癌效应(尤其是非遗传毒性化学物质)可能阈值的研究。